Torrent Pharma recalls bottles of Telmisartan, Hydrochlorothiazide tablets in US
According to the US health regulator, the drug maker is recalling the affected lot due to it being "Superpotent; Hydrochlorothiazide."
New Delhi: Torrent Pharma is recalling more than 27,000 bottles of its generic drug, used in lowering high blood pressure, in the US market. As per the latest enforcement report by the US Food and Drug Administration (USFDA), the Ahmedabad-based company is recalling 27,312 bottles of the Telmisartan and Hydrochlorothiazide tablets.
Read also: Lupin recalls cartons of oral contraceptive drug Tydemy in US
Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Read also: Torrent pharma successfully completes USFDA inspection for Levittown facility
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd